New Decade, New Pharmacy Model

Puzzle Pieces

by David Pope, PharmD, CDE, Chief Innovation Officer

More pharmacists are scheduling patient appointments and providing billable clinical services with patients than ever before. Immunizations have been an effective and profitable entry into clinical services for pharmacies, with 90 percent of pharmacies today providing an immunization service. The list of additional medical services, such as diabetes education and tobacco cessation, has grown exponentially in recent years but there’s still a lot of room to grow. Retail pharmacy is becoming a health hub for the community, and as we start a new decade, now is the time to engage in the ‘primary care pharmacist’ model.

So why are medical services such a significant area of growth in pharmacy? Pharmacists are demonstrating value by delivering education, accountability and diagnostic screenings that improve outcomes and lower overall healthcare costs. And the industry taking note.

A great example is chronic disease management. A study published in The Annals of Pharmacotherapy showed that patients who received care that included pharmacist involvement had adjusted A1c levels reduced by an average of 1.38 percentage points compared to those without pharmacist involvement. This is a clinically meaningful improvement, making it three times as likely for patients to achieve an A1c level of less than 7 percent when a pharmacist is engaged in care.

As a result of this and other studies that have demonstrated the value of pharmacists engaging in clinical care, multiple states have passed landmark laws that allow pharmacists to prescribe birth control, cholesterol medications, administer flu tests and more. Additionally, payers are noticing and are increasingly allowing pharmacists as medical providers into their preferred networks, even in states where provider status laws have yet to be passed.

The pharmacy landscape is rapidly changing to include service-based approaches that are proving to be a major factor in healthcare reform. Pharmacists face a unique opportunity to embrace the role of a ‘primary-care pharmacist’ while maintaining their role as the purveyors of medicine.

 

David Pope, PharmD, CDE Chief Innovation Officer

In his role as chief innovation officer, David Pope, PharmD, CDE, leads OmniSYS’s efforts to develop innovative solutions that support the evolving role of pharmacy in healthcare delivery. Dr. Pope is a nationally-recognized expert in medical informatics and clinical services in the pharmacy space, and has served as an advisor for the Center for Disease Control (CDC) as well as multiple Fortune 500 healthcare-related organizations.

More To Explore

Blog Post

How Can OmniSYS Help Your Pharmacy Support COVID-19?

From everyone here at OmniSYS, we are truly grateful for everything you are doing to serve and support your community during this challenging time. We have a number of updates available in OmniSYS solutions designed to help support your pharmacy as you navigate COVID-19.

Blog Post

Three Recommendations to Capture More Clinical Services Revenue

Because you assume the role of provider in clinical encounters, reimbursement looks very different than it does for your standard pharmacy transitions. Here are three key challenges when it comes to capturing clinical services revenue, and recommendations on how you can overcome these challenges.